ReShape Lifesciences Inc
NASDAQ:RSLS

Watchlist Manager
ReShape Lifesciences Inc Logo
ReShape Lifesciences Inc
NASDAQ:RSLS
Watchlist
Price: 3.92 USD 22.5% Market Closed
Market Cap: $290.2m

Net Margin

-48.3%
Current
Improving
by 149.7%
vs 3-y average of -198%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-48.3%
=
Net Income
$-3.5m
/
Revenue
$7.2m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-48.3%
=
Net Income
$-3.5m
/
Revenue
$7.2m

Peer Comparison

Country Company Market Cap Net
Margin
US
ReShape Lifesciences Inc
NASDAQ:RSLS
1.2B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.8B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
186.8B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
137.1B USD
Loading...
US
Stryker Corp
NYSE:SYK
135.7B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129.3B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.6B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.1B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.5B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.6B USD
Loading...
US
Resmed Inc
NYSE:RMD
36.8B USD
Loading...

Market Distribution

Lower than 81% of companies in the United States of America
Percentile
19th
Based on 15 072 companies
19th percentile
-48.3%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

ReShape Lifesciences Inc
Glance View

Market Cap
290.2m USD
Industry
Health Care

ReShape Lifesciences, Inc. operates as a medical device company, which focuses on technology to treat obesity and metabolic diseases. The company is headquartered in San Clemente, California and currently employs 47 full-time employees. The company went IPO on 2016-10-06. The firm is focused on offering an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band and associated program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The ReShape Vest System is an investigational minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery. The ReShapeCare Virtual health coaching program is a virtual telehealth weight management program that supports lifestyle changes for all weight-loss patients, to help them keep the weight off over time. The firm's Obalon Balloon System is intended for adults with a body mass index (BMI) of 30 to 40 kilograms/ square meter.

RSLS Intrinsic Value
8.48 USD
Undervaluation 54%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-48.3%
=
Net Income
$-3.5m
/
Revenue
$7.2m
What is ReShape Lifesciences Inc's current Net Margin?

The current Net Margin for ReShape Lifesciences Inc is -48.3%, which is above its 3-year median of -198%.

How has Net Margin changed over time?

Over the last 3 years, ReShape Lifesciences Inc’s Net Margin has increased from -517.9% to -48.3%. During this period, it reached a low of -590.6% on Jun 30, 2022 and a high of -48.3% on Apr 3, 2025.

Back to Top